Human ageing process biologically reversed in world first

 

The ageing process has been biologically reversed for the first time by giving humans oxygen therapy in a pressurised chamber.

Scientists in Israel showed they could turn back the clock in two key areas of the body believed to be responsible for the frailty and ill-health that comes with growing older.

As people age, the protective caps at the ends of chromosomes – called telomeres – shorten, causing DNA to become damaged and cells to stop replicating. At the same time, "zombie" senescent cells build up in the body, preventing regeneration.

Increasing telemere length and getting rid of senescent cells is the focus of many anti-ageing studies, and drugs are being developed to target those areas.

Now scientists at Tel Aviv University have shown that giving pure oxygen to older people while in a hyperbaric chamber increased the length of their telomeres by 20 per cent, a feat that has never been achieved before.

Scientists said the growth may mean that the telomeres of trial participants were now as long as they had been 25 years earlier.

https://www.yahoo.com/news/human-ageing-process-biologically-reversed-153921785.html 

Former CDC Head Cashes In At Merck

Story at-a-glance

• In January 2020, Dr. Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention, who after leaving the CDC became president of Merck’s vaccine division, sold half her Merck stock options for $9.11 million
• Gerberding also cashed out in 2016, when she sold $5.1 million in Merck stocks, and 2015, when she made $2.3 million. In total, Gerberding has made $16,592,144 from her company stock options
• Gerberding’s former high-level ties to the CDC likely has had enormous influence over Merck’s financial growth, considering Merck makes a majority of the pediatric and adults vaccines recommended by the CDC
• Red flags have recently been raised about Merck’s HPV vaccine Gardasil, a vaccine Gerberding promoted in a 2004 report to Congress before it was fast tracked to licensure in 2006. The U.K. recently reported a 54% rise in cervical cancer among 24- to 29-year-olds, the first generation to receive the HPV vaccine
• A January 2020 report in the Journal of the Royal Society of Medicine warns HPV vaccine trials have not been designed to detect whether the vaccine actually prevents cervical cancer. Trials have shown, however, that Gardasil raises the risk of cervical cancer by 44.6% among women with a current or previous HPV infection
•  
• Read more: https://articles.mercola.com/sites/articles/archive/2020/03/06/julie-gerberding-merck.aspx?cid_source=dnl&cid_medium=email&cid_content=art1HL&cid=20200306Z1&et_cid=DM473197&et_rid=824174238